A study funded by Israeli pharma and generics player Teva (NYSE: TEVA) has contributed to the growing body of real-world ...

California-based Braveheart Bio, a biotech developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and related cardiovascular conditions, has announced that Marc Evanchik has ...

The US Federal Trade Commission has hailed what it calls a ‘landmark settlement’ with one of the nation’s largest pharmacy ...

US drugmaker AbbVie closed Wednesday’s trading 4% lower Wednesday after presenting its fourth quarter and 2025 financial ...

Danish pharma major Novo Nordisk said on Tuesday it had appointed Jamey Millar head of its US business, and Hong Chow head of ...

Russia faces a significant increase in the number of cancelled tenders during drug procurements for state needs, which is ...

As Chugai marks its 100th anniversary, new Chugai Pharma Europe managing director Nicolas Henriot reflects on a fast-moving first 100 days, the organisation’s evolving role within the global group, ...

Swedish Orphan Biovitrum, the Nordic biotech company also known as Sobi, today announced positive third-quarter 2025 ...

Indian pharma major Lupin (BSE: 500257) has launched topiramate extended-release capsules in the USA after receiving approval ...

US pharma major Bristol Myers Squibb (NYSE: BMY) reported fourth-quarter 2025 revenues of $12.5 billion, up 1%, with GAAP ...

The global proteomics market was valued at $29.9 billion in 2025 and is forecast to grow to $58.7 billion by 2031, according ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued final draft guidance ...